[{"data": {"name": "Regular and low-dose aspirin, other non-steroidal anti-inflammatory medications and prospective risk of HER2-defined breast cancer: the California Teachers Study", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "Christina A. Clarke", "@type": "Person"}, {"name": "Alison J. Canchola", "@type": "Person"}, {"name": "Lisa M. Moy", "@type": "Person"}, {"name": "Susan L. Neuhausen", "@type": "Person"}, {"name": "Nadia T. Chung", "@type": "Person"}, {"name": "James V. Lacey", "@type": "Person"}, {"name": "Leslie Bernstein", "@type": "Person"}], "license": "cc-by", "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "https://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0840-7", "encodingFormat": "application/pdf"}, {"@type": "MediaObject", "contentUrl": "http://europepmc.org/articles/pmc5410689?pdf=render", "encodingFormat": "application/pdf"}], "publisher": {"name": "Springer Science and Business Media LLC", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1186/s13058-017-0840-7", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCHoGcWcdFUsT-CTPCE65GxsTa4-CD5VKU4nucgAZ-CRm6LoLiShT8L", "propertyID": "ISCC"}], "datePublished": "2017-05-01"}, "schema": "schema.org", "mediatype": "application/ld+json"}]